Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	MRKMerck & Co.	JNJJohnson & Johnson	PFEPfizer
Snapshot
Price	$115.48	$231.29	$25.08
Market cap	$281.24B	$549.78B	$143.68B
Valuation
P/E	31.4x	26.1x	19.1x
Forward P/E	44.8x	27.2x	20.2x
Growth
Revenue growth	2.9%	7.9%	1.4%
EPS growth	-48.3%	-3.9%	-5.3%
Profitability
Net margin	13.6%	21.8%	11.8%
ROE	17.9%	26.3%	8.4%
Balance sheet & cash
Debt / equity	0.94x	0.59x	0.75x
Free cash flow yield	2.9%	3.2%	11.2%
Dividend yield	3.0%	2.3%	6.6%
Verdict
Investment rating	Weak· 40	Neutral· 56	Neutral· 48

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	MRKtoday $115	JNJtoday $231	PFEtoday $25
2027	$88.34 – $129.57+12% CAGR	$176.94 – $259.51+12% CAGR	$19.19 – $28.14+12% CAGR
2028	$90.11 – $132.16+7% CAGR	$180.48 – $264.70+7% CAGR	$19.57 – $28.70+7% CAGR
2029	$91.91 – $134.80+5% CAGR	$184.09 – $269.99+5% CAGR	$19.96 – $29.28+5% CAGR
2030	$93.75 – $137.50+4% CAGR	$187.77 – $275.39+4% CAGR	$20.36 – $29.86+4% CAGR
2031	$95.62 – $140.25+4% CAGR	$191.52 – $280.90+4% CAGR	$20.77 – $30.46+4% CAGR
5-yr CAGR	-3.7% – 4.0%	-3.7% – 4.0%	-3.7% – 4.0%